BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35537764)

  • 1. Neurolymphomatosis: an uncommon manifestation of lymphoma - detection and therapeutic monitoring through 18F-fluorodeoxyglucose positron-emission tomography and computed tomography imaging.
    Hui SY; Wong A; Nambiar M; Ramdave S
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537764
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing PET/CT manifestation of neurolymphomatosis.
    Strobel K; Pestalozzi B; Ciernik I; Schaefer NG; Koma AY; Hany TF
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1244. PubMed ID: 16823555
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of neurolymphomatosis].
    Gelezhe PB; Medvedeva AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):150-153. PubMed ID: 36036417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
    Ganeshalingam R; Roach P; Schembri GP
    Clin Nucl Med; 2019 Feb; 44(2):145-147. PubMed ID: 30516683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and
    Switlyk MD; Skeie AT; Lund-Iversen M; Østenstad B
    Ann Hematol; 2020 Jan; 99(1):203-205. PubMed ID: 31768676
    [No Abstract]   [Full Text] [Related]  

  • 6. Bottle brush sign by
    De Bonilla-Candau M; Moreno-Ballesteros A; Tortajada-Bustelo CJ; Cardozo-Saavedra A; Aguadé-Bruix S
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(4):279-280. PubMed ID: 37269982
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Chague P; Phan CM; Lapusan S; Zhang-Yin J; Cottereau AS
    Diagn Interv Imaging; 2019 Sep; 100(9):527-528. PubMed ID: 30853415
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
    Jeong J; Kim SW; Sung DH
    J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurolymphomatosis in follicular lymphoma: an autopsy case report.
    Ando T; Kamoshita S; Riku Y; Ito A; Ozawa Y; Miyamura K; Fujino M; Ito M; Goto Y; Mano K; Akagi A; Miyahara H; Katsuno M; Yoshida M; Iwasaki Y
    Neuropathology; 2022 Aug; 42(4):295-301. PubMed ID: 35607714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fallacy of Quantifying Lymphoma Activity by Scaling to the Liver in [18F]Fluorodeoxyglucose Positron Emission Tomography (Deauville criteria).
    Keramida G; Peters AM
    J Clin Oncol; 2015 Dec; 33(34):4120-1. PubMed ID: 26304889
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurolymphomatosis of multifocal peripheral nerve involvement: a case report.
    Peng L; Yang H; Zhao Y; He J; Stebbing J; Chen B
    Ann Palliat Med; 2022 Jul; 11(7):2529-2537. PubMed ID: 34670378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose positron emission tomography/computed tomography of bilateral primary ureter lymphoma.
    Yin L; Zhen Y; Lin Z; Li W; Meng Z
    Korean J Intern Med; 2021 May; 36(3):748-750. PubMed ID: 32872733
    [No Abstract]   [Full Text] [Related]  

  • 13. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
    von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
    Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative positron emission tomography imaging for response assessment of [18F]fluorodeoxyglucose-avid lymphomas: should we report standard uptake value confidence limits?
    Laffon E; Marthan R
    J Clin Oncol; 2015 Apr; 33(10):1218-9. PubMed ID: 25691673
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurolymphomatosis of the sciatic and tibial nerves as an initial presentation of lung diffuse large B cell lymphoma detected by positron emission tomography/computed tomography.
    Narita K; Kobayashi H; Kitadate A; Abe Y; Miura D; Takeuchi M; Matsue K
    Int J Hematol; 2019 Oct; 110(4):385-386. PubMed ID: 31309418
    [No Abstract]   [Full Text] [Related]  

  • 16. Occult optic nerve neurolymphomatosis of T-lymphoblastic lymphoma detected by PET/MRI.
    Shen K; Yang C
    Br J Haematol; 2023 May; 201(4):598. PubMed ID: 36971077
    [No Abstract]   [Full Text] [Related]  

  • 17. 18F-FDG PET/CT Findings of Granulomatosis With Polyangiitis Mimicking Malignant Lymphoma.
    Tian Y; Zhang Y; Wen B; Li C; He Y
    J Clin Rheumatol; 2021 Aug; 27(5):e194-e195. PubMed ID: 32251059
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurolymphomatosis Mimicking Inflammatory Neuropathy with Slight FDG Uptake on PET/CT and Distinct MRI Abnormalities in the Brachial Plexus: A Case Report].
    Shima T; Tsujino A
    Brain Nerve; 2020 Sep; 72(9):987-992. PubMed ID: 32934188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of widespread neurolymphomatosis with 18F-FDG PET.
    Oztürk E; Arpaci F; Kocaoğlu M; Arslan N; Bulakbaşi N; Ozgüven M
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):975-6. PubMed ID: 16703365
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurolymphomatosis of the median nerve, optic nerve, L4 spinal nerve root and cauda equina in patients with B-cell malignancies: a case series.
    Alazawi S; Elomri H; Taha R; Bakr M; Abdelhamid MT; Szabados L; Yassin M; Sabah HE; Aboudi K; Ellahie A; Fadul A; Gameil A; Al Battah A; Fernyhough LJ
    J Med Case Rep; 2021 Mar; 15(1):133. PubMed ID: 33766128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.